2.5 mg
Trade Name
Methotrexate BOS
Tablet
Request Type
New Registration
Drug Type
Generic(Multisource) Drug
Approval Date
SFDA Approved Use
Antirheumatic
Active rheumatoid arthritis in adult patients where treatment with disease modifying antirheumatic drugs (DmARDs) is indicated.
Polyarthritic forms of severe, active juvenile idiopathic arthritis (JIA) when the response to nonsteroidal anti-inflammatory drugs (NSAIDs) has been inadequate.
Antipsoriatic
Severe and generalized psoriasis vulgaris, especially plaque-type, in adults which cannot be sufficiently treated with conventional therapy such as phototherapy, PUVA, and retinoids.
Cytostatic
Maintenance treatment in acute lymphatic leukaemia.
Active rheumatoid arthritis in adult patients where treatment with disease modifying antirheumatic drugs (DmARDs) is indicated.
Polyarthritic forms of severe, active juvenile idiopathic arthritis (JIA) when the response to nonsteroidal anti-inflammatory drugs (NSAIDs) has been inadequate.
Antipsoriatic
Severe and generalized psoriasis vulgaris, especially plaque-type, in adults which cannot be sufficiently treated with conventional therapy such as phototherapy, PUVA, and retinoids.
Cytostatic
Maintenance treatment in acute lymphatic leukaemia.